Finding 593068 (2022-001)

Significant Deficiency
Requirement
AE
Questioned Costs
$1
Year
2022
Accepted
2023-03-30
Audit: 22102
Organization: Wake Forest University (NC)
Auditor: Kpmg LLP

AI Summary

  • Core Issue: Claims submitted for reimbursement included patients who were not uninsured at the time of service, violating program requirements.
  • Impacted Requirements: The university failed to maintain effective internal controls as required by federal regulations, leading to improper claims totaling $1,504.
  • Recommended Follow-Up: Enhance controls to ensure timely identification of any insurance coverage changes to prevent future improper claims and ensure refunds to HRSA.

Finding Text

Finding No. 2022-001: Allowability and Eligibility Federal Program: COVID-19 ? Claims Reimbursement Program for the Uninsured for the COVID-19 Coverage Assistance FundCriteria or Requirement(ALN 93.461) Federal Award Year: July 1, 2021 through June 30, 2022 Federal Award Agency U.S. Department of Health and Human Services Ciiteria or RequirementPer the terms and conditions of the award, the recipient certifies that the patients identified on the claim form were uninsured individuals at the time the services were provided. Per 2 CFR 200.303, the nonfederal entity must establish and maintain effective internal control over the Federal award that provides reasonable assurance that the nonfederal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. Condition Found, Including Perspective For 2 out of 40 patients sampled, the patient had Medicaid or other insurance coverage that was applied subsequently, for the time-period of services provided. Wake Forest University Health Sciences did not refund Health Resources and Services Administration (HRSA) for the amount that was paid on these claims. The amount paid on these claims was $1,504 and the sampled population was $7,551. Possible Cause and Asserted Effect Wake Forest University Health Science?s internal controls failed to prevent the subsequently identified insurance coverage from being added as secondary coverage to HRSA and therefore, the patient claim was submitted to and reimbursed by HRSA and not refunded. Questioned Costs $1,504 Statistical Validity The sample was not intended to be, and was not, a statistically valid sample. Repeat Finding in the Prior Year No. Recommendation We recommend the University enhance the precision of the control around timely identification of coverages added subsequent to the normal control process (but applies to earlier dates of service) which would require refund to HRSA.

Categories

Questioned Costs Cash Management Eligibility Matching / Level of Effort / Earmarking Internal Control / Segregation of Duties

Other Findings in this Audit

  • 16626 2022-001
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
84.268 Federal Direct Student Loans $40.50M
84.033 Federal Perkins Loan Program $9.27M
93.RD Lung Organ Tissue Equivalent Platform for Modeling Chlorine Gas Toxicology $8.78M
84.425 Education Stabilization Fund $3.84M
84.181 Special Education-Grants for Infants and Families $3.33M
84.063 Federal Pell Grant Program $2.54M
98.001 Usaid Foreign Assistance for Programs Overseas $1.29M
12.RD Determining the Fundamental Differences Among Tissue Organoids From Different Species $1.23M
93.461 Covid-19 Testing for the Uninsured $1.07M
93.243 Substance Abuse and Mental Health Services_projects of Regional and National Significance $774,017
93.RD Nc Corva Seq Network $755,715
93.RD Women Health Initiative - Regional Center $742,615
93.RD Applied Research to Address the Covid-19 Emerging Public $694,947
93.917 Hiv Care Formula Grants $688,191
84.007 Federal Supplemental Educational Opportunity Grants $645,078
93.RD Multi-Ethnic Study of Atherosclerosis (mesa) $575,714
20.RD Crash Injury Research Engineering Network Center $572,161
84.033 Federal Work-Study Program $550,114
12.340 Naval Medical Research and Development $543,880
12.RD Remdo Ati $468,301
93.RD Whims-Echo Hormone Therapy and Cognitive Aging in Older Postmenopausal Women $415,645
45.130 Promotion of the Humanities_challenge Grants $410,981
81.049 Office of Science Financial Assistance Program $407,361
93.RD Elc Project K8 Threat of Antibiotic-Resistant Gonorrhea $396,465
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $361,858
93.211 Telehealth Programs $264,105
47.050 Geosciences $259,610
93.RD Petal Network International Coordinatinc Center for Activ-3 Trial Initiative $236,050
59.075 Shuttered Venue Operators Grant Program $215,735
93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders $210,858
93.RD Multicenter Platform Evaluating Putative Therapeutics for the Treatment of Covid-19 in Hospitalized Adults $209,967
93.941 Hiv Demonstration, Research, Public and Professional Education Projects $208,626
93.RD Atherosclerosis Risk in Communities (aric) Field Center $206,382
93.945 Assistance Programs for Chronic Disease Prevention and Control $188,195
47.070 Computer and Information Science and Engineering $183,570
47.074 Biological Sciences $174,003
93.310 Trans-Nih Research Support $158,716
92.213 Research and Training in Complementary and Integrative Health $154,617
93.889 National Bioterrorism Hospital Preparedness Program $150,000
93.RD Covid-19 Post-Hospital Thrombosis Prevention Study $135,276
21.019 Coronavirus Relief Fund $126,980
93.107 Area Health Education Centers Point of Service Maintenance and Enhancement Awards $124,131
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $122,868
43.RD Science $116,629
93.RD Randomized Master Protocol for Immune Modulators $114,607
12.431 Basic Scientific Research $111,261
93.RD Enhanced Rapid Assay for Monitoring Immunosuppressant $110,460
47.076 Education and Human Resources $108,906
93.978 Preventive Health Services_sexually Transmitted Diseases Research, Demonstrations, and Public Information and Education Grants $100,754
93.RD Ivy: Covid-19 Ancillary Studies $93,618
93.RD Medical Imaging and Data Consortium $88,311
12.630 Basic, Applied, and Advanced Research in Science and Engineering $88,124
43.003 Exploration $82,458
93.394 Cancer Detection and Diagnosis Research $81,834
93.421 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nations Health $80,208
93.250 Geriatric Academic Career Awards Department of Health and Human Services (b) $71,475
93.334 The Healthy Brain Initiative: Technical Assistance to Implement Public Health Actions Related to Cognitive Health, Cognitive Impairment, and Caregiving at the State and Local Levels $70,073
93.350 National Center for Advancing Translational Sciences $67,987
45.164 Promotion of the Humanities_public Programs $65,637
93.RD Molecular Basis of Exercise-Induced Changes in Hdl Function $64,878
10.310 Agriculture and Food Research Initiative (afri) $63,758
12.RD Development of A Universal Bioreactor Platform for Regenerative Medicine Clinical Manufacturing $59,785
93.226 Research on Healthcare Costs, Quality and Outcomes $58,433
93.213 Research and Training in Complementary and Integrative Health $47,975
93.RD Optopharmacology and Sensors for Dissecting Opiate Actio $47,398
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $43,483
93.RD Whims Investigating the Biology of Cognitive Resilience $42,432
93.RD Chs Research for the Cardiovascular Health $40,743
12.RD Immunopathology, Fluorescent Imaging and Histomorphomet $40,108
93.RD Atherosclerosis Risk in Communities (aric) - Coordinating Center $37,490
93.RD Jackson Heart Surveillance Study (jhs Surveillance) $36,771
93.242 Mental Health Research Grants $36,729
93.103 Food and Drug Administration_research $35,691
93.865 Child Health and Human Development Extramural Research $35,688
47.075 Social, Behavioral, and Economic Sciences $32,912
93.351 Research Infrastructure Programs $32,486
93.279 Drug Abuse and Addiction Research Programs $32,250
12.RD Neocare Platform to Prolong Tissue Preservation $31,246
93.153 Coordinated Services and Access to Research for Women, Infants, Children, and Youth $31,109
93.837 Cardiovascular Diseases Research $29,934
81.RD Directed Electrode Nanostructure Engineering $28,620
93.273 Alcohol Research Programs $28,536
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $27,040
93.866 Aging Research $26,701
93.859 Biomedical Research and Research Training $26,043
93.307 Minority Health and Health Disparities Research $25,091
93.121 Oral Diseases and Disorders Research $24,935
93.RD Impact of Nicotine Reduction on Adolescent Cigarette Use $24,835
93.924 Ryan White Hiv/aids Dental Reimbursement and Community Based Dental Partnership Grants $24,692
93.172 Human Genome Research $24,553
93.395 Cancer Treatment Research $23,358
93.124 Nurse Anesthetist Traineeships $22,326
93.867 Vision Research $20,268
93.RD A Randomized Phase Ii/iii Study of Conventional $20,259
93.359 Nurse Education, Practice Quality and Retention Grants $20,021
93.080 Blood Disorder Program: Prevention, Surveillance, and Research $19,111
93.RD Department of Defense $17,643
93.839 Blood Diseases and Resources Research $17,492
93.RD Adaptive Platform Treatment Trial for Outpatients with Covid-19 (adapt Out Covid) $16,637
93.110 Maternal and Child Health Federal Consolidated Programs $16,291
47.041 Engineering $15,594
93.361 Nursing Research $15,584
93.RD Intergovernmental Personnel Act Mobility Program $15,570
93.RD Effectiveness of Ha Mrna-Lnp Vaccines in Newborn Nhp $15,539
93.113 Environmental Health $14,681
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $14,461
12.RD Assembly of Topologic $13,739
93.RD Cancer Research $13,198
93.397 Cancer Centers Support Grants $13,141
93.399 Cancer Control $12,897
93.RD Piedmont Triad Regional Council Area Agency on Aging $12,837
93.855 Allergy, Immunology and Transplantation Research $12,780
93.RD Change in Relative Cerebral Blood Volume As A Biomarker $12,726
93.RD Electronic Health Record (ehr)-Embedded Decision Support $12,650
93.989 International Research and Research Training $11,461
64.RD Collaboration for Developing A Virtual Reality App $11,198
93.398 Cancer Research Manpower $11,046
93.RD Characterizing Home Activity for Cancer Health Awareness (cha-Cha) $10,585
93.RD Covid-19 Imaging Research Registry (cirr) $10,440
93.RD Sexually Transmitted Infections Clinical Trials Group Admin Core $9,405
93.RD Phase III Trial of Stereotactic Radiosurgery (srs) $9,343
93.393 Cancer Cause and Prevention Research $9,148
93.879 Medical Library Assistance $9,129
93.RD Ai-Based Multi-Functional Hand-Held $9,108
93.RD Randomized Phase III Trial of Bortezomib Lenalidomide A $8,332
93.396 Cancer Biology Research $8,109
93.077 Family Smoking Prevention and Tobacco Control Act Regulatory Research $7,966
19.040 Public Diplomacy Programs $7,594
93.RD A Phase II Study of Inotuzmab Ozogamcin $7,501
93.RD Intergovernmental Personnel Act of 1970 $6,616
93.RD Adcc Passive Transfer and Dengue Virus Challenge $6,105
93.RD Evaluating Fitness-for-Use Electronic Health Records $5,379
93.838 Lung Diseases Research $5,371
93.RD Chips (chilled Platelet Study) $4,571
93.969 Pphf Geriatric Education Centers $4,511
93.RD Randomized Phase III Study of Ibrutinib (pci-32765)-Based Therapy $4,477
93.RD Optimal Perioperative Therapy for Incidental Gallbladder $3,974
93.173 Research Related to Deafness and Communication Disorders $3,707
66.509 Science to Achieve Results (star) Research Program $3,667
47.049 Mathematical and Physical Sciences $3,576
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $2,160
93.RD Phase III Trial of Salvage Stereotactic Radiosurgery $1,999
93.262 Occupational Safety and Health Program $1,336
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $1,301
12.RD Prospective Study of Early Mechanical Stabilization and Bleeding in Disruption of the Pelvic Ring $1,002
93.073 Birth Defects and Developmental Disabilities - Prevention and Surveillance $868
12.420 Military Medical Research and Development $543
93.RD Clinical-Trial of Covid-19 Convalescent Plasma in Outpatience (c3po) $388
47.073 Office of Science and Technology Infratructure Programs $44
12.300 Basic and Applied Scientific Research $5